Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
HOBt in Peptide Coupling and Indazole SAR
2026-09-04
HOBt (1-Hydroxybenzotriazole) is more than a conventional peptide coupling additive: its activated-ester chemistry can shape stereochemical quality and downstream medicinal chemistry decisions. This article connects HOBt-enabled amide bond formation with the modular synthesis and assay interpretation of indazole glucagon receptor antagonists.
-
BOP Reagent for Prodrug Synthesis Workflows
2026-09-04
BOP reagent provides a practical route to carboxyl group activation, phenyl ester preparation, and controlled amide bond formation in research-scale synthesis. This workflow guide connects peptide-coupling discipline with carrier-free triterpene prodrug research while clearly separating established study findings from proposed chemical adaptations.
-
Clozapine N-oxide for DREADDs Workflows
2026-09-03
Clozapine N-oxide (CNO) enables reversible, cell-selective control of neuronal circuits through engineered muscarinic receptors. This workflow-oriented guide shows how to apply it to aversion studies, GPCR signaling research, assay validation, and troubleshooting without overinterpreting behavioral outcomes.
-
Octyl-α-ketoglutarate: A Causal HIF-1α Assay Tool
2026-09-03
Octyl-α-ketoglutarate is a cell-permeable prolyl hydroxylase substrate for testing how α-ketoglutarate availability shapes HIF-1α regulation. This guide presents a causal assay framework that separates substrate rescue from broader metabolic and hypoxia effects.
-
CP-673451 Workflow for PDGFRα/β Research
2026-09-02
CP-673451 is a selective PDGFRα/β inhibitor for linking receptor phosphorylation, PDGF-BB-driven angiogenesis, and glioma cell phenotypes in one experimental strategy. This practical guide covers dose design, ATRX-stratified assays, xenograft interpretation, formulation, and troubleshooting.
-
Tomivosertib: Translating MNK–eIF4E Biology
2026-09-02
Tomivosertib is more than a potent MNK1 inhibitor: it is a translational probe for testing how MNK1/2-dependent eIF4E phosphorylation shapes leukemic fitness, treatment response, neuronal excitability, angiogenesis, and metabolic adaptation. This article outlines the mechanistic rationale, evidence hierarchy, assay strategy, and decision points needed to move MNK-eIF4E research toward clinically relevant hypotheses.
-
Ertugliflozin (PF-04971729) Research Workflows
2026-09-01
Build cleaner renal glucose transport assays with the highly selective SGLT2 inhibitor Ertugliflozin (PF-04971729). This workflow-focused guide connects glucose reabsorption inhibition with body-weight, renal, cardiovascular, and fracture-safety readouts while emphasizing practical controls and troubleshooting.
-
Ibuprofen Workflows for Cell and Cancer Research
2026-09-01
Build more reproducible Ibuprofen experiments by connecting solvent handling, dose design, apoptosis induction in colon carcinoma cells, and cell-cycle profiling. This guide also adapts a protein–ligand workflow from a molecular pharmacology study without treating findings from mubritinib as direct evidence for Ibuprofen.
-
Fingolimod (FTY720) for Immune-Cell Assays
2026-08-31
Fingolimod (FTY720) gives researchers a controllable way to interrogate S1P-dependent lymphocyte trafficking, ERK signaling, and BDNF-associated neurobiology. Used as a mechanistic perturbation rather than an unproven CAR-T component, it can sharpen magnetic T-cell engineering assays and reveal how cell distribution affects efficacy.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-08-31
Grafton et al. developed a scalable phenotypic screening strategy that combines induced pluripotent stem cell-derived cardiomyocytes, high-content imaging, and deep learning to detect cardiotoxic patterns. Screening 1,280 bioactive compounds showed that a single deep-learning score could prioritize chemically and mechanistically diverse liabilities, while also revealing the need for orthogonal validation before biological or regulatory decisions.
-
Oligo (dT) 25 Beads for mRNA Workflows
2026-08-30
Oligo (dT) 25 Beads provide a selective, magnet-assisted route from total RNA or tissue lysate to polyadenylated mRNA for cDNA synthesis, RT-PCR, and sequencing. This guide translates a cisplatin-resistance transcriptomics study into practical capture, QC, assay-design, and troubleshooting decisions.
-
Caged Bioluminescent Probe for the Immunoproteasome
2026-08-29
Loy and Trader present a protocol for synthesizing and applying a cleavable, bioluminescent activity-based probe selective for the immunoproteasome, particularly the β5i catalytic subunit. The workflow connects peptide-probe chemistry with live-cell and plate-reader assays, while a tissue-mimic experiment suggests a path toward deeper optical studies without establishing in vivo performance.
-
Tobramycin: Designing Better Resistance Assays
2026-08-28
Tobramycin is an aminoglycoside antibiotic widely used to examine bacterial protein synthesis inhibition and resistance. This article converts historical comparative MIC data into a modern framework for improving assay design, formulation control, and interpretation in microbiology research.
-
NSAIDs and Canine Osteosarcoma Cell Viability
2026-08-28
Royals and colleagues compared deracoxib and piroxicam in canine osteosarcoma and fibroblast cultures, showing that deracoxib produced concentration-dependent loss of tumor-cell viability at lower concentrations than piroxicam while sparing fibroblasts. The findings support a selective in vitro cytotoxic effect at intermediate or high exposure, but they do not establish activity at typical canine plasma concentrations or demonstrate apoptosis.
-
Thapsigargin Workflows for SERCA Pump Inhibition
2026-08-27
Thapsigargin provides a fast, mechanistically defined way to connect calcium flux with endoplasmic reticulum stress, apoptosis, and reporter-based pathway analysis. This workflow guide shows how to use it as a controlled stressor, interpret assay timing, and troubleshoot variable calcium or viability results.